Skip to main content
. 2021 Apr;12(2):516–526. doi: 10.21037/jgo-20-494

Figure 3.

Figure 3

DFS between the three HIPEC regimens. OX-HIPEC vs. OX-HIPEC + EPIC P=0.33, OX-HIPEC vs. OXIRI-HIPEC P=0.049 (total n=133). DFS, disease-free survival; HIPEC, hyperthermic intraperitoneal chemotherapy; OX-HIPEC, oxaliplatin-based HIPEC; EPIC, post-operative intraperitoneal chemotherapy; OXIRI-HIPEC, oxaliplatin-irinotecan-based HIPEC.